ASCO GU 2023: CRPC updates from gu college study Watch Video
Preview(s):
Gallery
Play Video: (Note: The default playback of the video is HD VERSION. If your browser is buffering the video slowly, please play the REGULAR MP4 VERSION or Open The Video below for better experience. Thank you!)
⏲ Duration: 13 min 81 sec ✓ Published: 19-Feb-2023
Description: Dr Neal Shore (Carolina Urologic Research Center, Myrtle Beach, USA), Dr Elena Castro (Spanish National Cancer Research Center, Madrid, Spain), Prof Eleni Efstathiou (Houston Methodist Cancer Center, Houston, USA) and Prof Gerhardt Attard (University College London: Cancer Institute, London, UK) discuss the latest in CRPC. Prof Attard talks about rucaparib for metastatic castration-resistant prostate cancer (mCRPC) in the TRITON3 interim overall survival and the efficacy of rucaparib versus doce
Play Video: (Note: The default playback of the video is HD VERSION. If your browser is buffering the video slowly, please play the REGULAR MP4 VERSION or Open The Video below for better experience. Thank you!)